Equillium (EQ) Exchange Rate Effect (2019 - 2026)
Equillium (EQ) posted quarterly Exchange Rate Effect of $3000.0 for Q1 2026, up 400.0% year-over-year from $600.0 in Q1 2025, and down 92.31% quarter-over-quarter from $39000.0 in Q4 2025.
Equillium (EQ) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Equillium (EQ) has reported Exchange Rate Effect for 8 consecutive years, with $3000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 400.0% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $51000.0 (up 176.12% YoY), while the FY2025 annual figure was $47000.0, up 156.63% from the prior year.
- Exchange Rate Effect eased to $3000.0 in Q1 2026 per EQ's latest filing, from $39000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $48000.0 in Q3 2024 and bottomed at -$133000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$8588.2 across 5 years, with a median of -$3000.0 in 2022.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 1800.0% — and 2026, when it surged 400.0%.
- Equillium's Exchange Rate Effect stood at $31000.0 in 2022, then sank by 148.39% to -$15000.0 in 2023, then tumbled by 786.67% to -$133000.0 in 2024, then surged by 129.32% to $39000.0 in 2025, then plunged by 92.31% to $3000.0 in 2026.
- Business Quant data shows EQ's Exchange Rate Effect at $3000.0 in Q1 2026, $39000.0 in Q4 2025, and -$13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22,000.00 |
| Jun 30, 2026 | -22,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Dec 31, 2024 | -133,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Mar 31, 2024 | -17,000.00 |